Nav: Home

US prediction models for kidney injury following angioplasty hold up in Japan

April 04, 2016

Models developed by the American College of Cardiology NCDR CathPCI Registry to predict the likelihood of angioplasty patients developing acute kidney injury and acute kidney injury requiring dialysis have proven to be effective among patients in Japan. This finding suggests these models may have international application as a preventive tool, according to a study published today in the Journal of the American College of Cardiology.

Acute kidney injury is a condition characterized by an abrupt or rapid decline in kidney function. It is the most common non-cardiac complication following angioplasty and is associated with an increased risk of other complications, as well as death. This condition often can be prevented, however, by administering fluids and using cholesterol-lowering medications before conducting the procedure. By knowing who is at highest risk for acute kidney injury, it is possible to take these steps and prevent this complication.

The prediction models from the NCDR CathPCI Registry were applied to records from 11,041 patients from the Japan Cardiovascular Database, a registry comprised of 16 centers, between September 2008 and May 2014. The acute kidney injury model used 11 variables for predicting this complication, including age, baseline presence of kidney impairment, a history of stroke or heart failure, and prior angioplasty. The acute kidney model involving dialysis used five variables: baseline presence of kidney impairment, diabetes, heart failure, presence of acute coronary syndrome, and cardiogenic shock.

Researchers found 10.1 percent of the patients experienced acute kidney injury and 1.5 percent had a kidney injury that required dialysis. Patients who experienced an acute kidney injury tended to be older, have more heart failure and kidney dysfunction prior to angioplasty, and a greater number of other medical conditions.

The study found that overall, the prediction model for acute kidney injury performed well. In the highest-risk group, the predicted incidence of acute kidney injury was 34 percent, compared to a 36 percent actual occurrence of the problem. Similar performance was observed among patients with and without acute coronary syndrome.

For patients with acute kidney injury requiring dialysis, the predicted risk was 4 percent, compared to a 9 percent observed incidence. This discrepancy showed that the model underestimated the risk of dialysis among the highest-risk patients. Once the model was adjusted properly, it was better able to stratify risk.

Taku Inohara, M.D., the study's lead author and a cardiologist at Keio University School of Medicine in Tokyo, said that "these findings support the use of the NCDR models in Japan" and pointed out that knowing a patient's risk for acute kidney injury enables the provider to tailor treatment accordingly. "Given the validity of the NCDR acute kidney injury models in Japan, future research on how to best leverage these insights about patient risk to minimize the onset of acute kidney injury is warranted," he said.

"This is an example of how registries, like NCDR, can provide important information that once it is validated--as it is in this paper--can change practice," said Valentin Fuster, M.D., Ph.D., Journal of the American College of Cardiology editor-in-chief.

In an accompanying editorial, Peter A. McCullough, M.D., M.P.H., FACC, vice chief of medicine at Baylor University Medical Center in Dallas, said that the study is "an excellent example of how the NCDR Registry can be used to generate meaningful tools for prediction of complications that are set up for external validation from populations outside of the United States." He adds that because there are increasing numbers of patients with advanced kidney disease undergoing angioplasty, "there is an urgent need for safer approaches for these high-risk patients."
-end-
The American College of Cardiology is a 52,000-member medical society that is the professional home for the entire cardiovascular care team. The mission of the College is to transform cardiovascular care and to improve heart health. The ACC leads in the formation of health policy, standards and guidelines. The College operates national registries to measure and improve care, provides professional medical education, disseminates cardiovascular research and bestows credentials upon cardiovascular specialists who meet stringent qualifications. For more information, visit acc.org.

The Journal of the American College of Cardiology, which publishes peer-reviewed research on all aspects of cardiovascular disease, is the most widely read cardiovascular journal worldwide. JACC is ranked No. 1 among cardiovascular journals worldwide for its scientific impact.

American College of Cardiology

Related Heart Failure Articles:

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.
Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.
Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.
Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.
How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.
Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
NSAID impairs immune response in heart failure, worsens heart and kidney damage
Non-steroidal anti-inflammatory drugs, or NSAIDs, are widely known as pain-killers and can relieve pain and inflammation.
Heart cell defect identified as possible cause of heart failure in pregnancy
A new Tel Aviv University study reveals that one of the possible primary causes of heart failure in pregnant women is a functional heart cell defect.
In heart failure, a stronger heart could spell worse symptoms
Patients with stronger-pumping hearts have as many physical and cognitive impairments as those with weaker hearts, suggesting the need for better treatment.
Patients with common heart failure more likely to have lethal heart rhythms
New Smidt Heart Institute Research shows that patients with Heart Failure with Preserved Ejection Fraction (HFpEF) are more likely to have lethal heart rhythms.
More Heart Failure News and Heart Failure Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Uncharted
There's so much we've yet to explore–from outer space to the deep ocean to our own brains. This hour, Manoush goes on a journey through those uncharted places, led by TED Science Curator David Biello.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 2: Every Day is Ignaz Semmelweis Day
It began with a tweet: "EVERY DAY IS IGNAZ SEMMELWEIS DAY." Carl Zimmer – tweet author, acclaimed science writer and friend of the show – tells the story of a mysterious, deadly illness that struck 19th century Vienna, and the ill-fated hero who uncovered its cure ... and gave us our best weapon (so far) against the current global pandemic. This episode was reported and produced with help from Bethel Habte and Latif Nasser. Support Radiolab today at Radiolab.org/donate.